Pierre Fabre Group
Pierre Fabre, a leading dermo-cosmetics and pharmaceutical group, is seeking a Global HEOR Director to develop strategies that demonstrate product value and differentiation, primarily in oncology, dermatology, and rare diseases. The role involves managing a team, collaborating across departments and with external entities, and influencing pricing and reimbursement conditions worldwide.
Founded in 1962 by Mr. Pierre Fabre, Pierre Fabre is an international French pharmaceutical and dermo-cosmetic group owned by a public benefit foundation and its employees.
Naos appoints Frédéric Ennabli, former Pierre Fabre executive, as board chairman
Sep 29, 2025
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
Oct 10, 2022
Pierre Fabre Has Acquired Dermocosmetics Brand Même
May 9, 2023
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pierre Fabre Group.
Pierre Fabre Group didn’t post a salary, so this is our estimate from similar listings.
14% above the average for this role
Eric Ducournau Named Chief Executive Officer of the Pierre Fabre Group
May 31, 2018
Global Health Economics & Outcomes Research (HEOR) Director
Ipsen
Director, HEOR Strategy, Global Immunology Pipeline
AbbVie
Director, HEOR Strategy - Aesthetics
AbbVie
Director, HEOR Strategy - Aesthetics
AbbVie
Director, Health Economics & Outcomes Research- Hematology Oncology
Regeneron Pharmaceuticals
Director, HEOR Strategy - Dermatology
AbbVie